XOMA Corp (NASDAQ:XOMA)

22.03
Delayed Data
As of Mar 24
 +1.74 / +8.58%
Today’s Change
15.68
Today|||52-Week Range
32.09
+19.73%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$223.1M

Company Description

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Contact Information

XOMA Corp.
2200 Powell Street
Emeryville California 94608
P:(510) 204-7200
Investor Relations:

Employees

Shareholders

Other institutional26.32%
Mutual fund holders20.53%
Individual stakeholders17.00%

Top Executives

Owen Patrick HughesChairman & Chief Executive Officer
Thomas BurnsChief Financial Officer & Senior VP-Finance
Bradley J. SitkoChief Investment Officer
Juliane SnowdenInvestor Relations Contact